The global brain implants market is on the verge of remarkable growth, with projections estimating a market value of USD 18 billion by 2032. This upward trajectory signifies a robust compound annual growth rate (CAGR) of 12.3%, driven by a confluence of critical factors highlighting the urgent need for groundbreaking medical solutions.
Currently valued at over USD 5.7 billion in 2022, the brain implants market is witnessing accelerated expansion. This surge is primarily fueled by the rising incidence of nervous system cancers, with GLOBOCAN 2020 data reporting approximately 308,102 cases of brain and nervous system cancers worldwide in 2020. This alarming prevalence, combined with an aging population in developed countries, underscores the pressing demand for advanced medical interventions.
The integration of state-of-the-art technologies customized to meet individual patient needs is also propelling market growth. As healthcare providers strive to improve treatment efficacy and patient outcomes, innovative brain implant solutions are becoming increasingly vital.
The increasing prevalence of conditions such as trauma, malignant tumors, and congenital deformities is driving the need for advanced brain implants. As the medical community emphasizes personalized care, the development of effective, technology-driven implants remains a key focus.
“We are witnessing a transformative phase in the brain implants market,” stated FMI. “The convergence of rising cancer cases, an aging population, and technological advancements is setting the stage for unprecedented growth in this sector.”
There are several factors that are propelling the demand for brain implants:
- Rising neurological disorders: As the population ages, there’s a growing need for treatment options for conditions like Parkinson’s disease, epilepsy, and depression. Brain implants offer a potential long-term solution for these patients when medication proves ineffective.
- Mental health needs: Conditions like stress and obesity-related depression are becoming more prevalent. Brain implant technologies are being explored as a possible treatment option for these conditions.
- Technological advancements: MRI and new technologies like deep brain stimulation are making brain implant surgery more precise and effective. This is leading to more patients being considered as candidates for this type of treatment.
- Improved mobility: Technologies like motor neuron prostheses, Brain Computer Interfaces (BCI), and micro electrode arrays are being used to help patients with mobility issues. These advancements are increasing the potential applications of brain implants.
Overall, the demand for brain implants is being driven by a combination of factors, including the growing need for treatment options for neurological and mental health conditions, along with the development of new and more sophisticated technologies.
Get the Full Picture: Download the Complete Brain Implants Market Report Here
Competitive Analysis:
Market players are continually advancing analytical solutions and broadening their product offerings. Companies in the brain implants market are concentrating on strategic alliances, technology collaborations, and product launch initiatives. Tier 2 players in the market are aiming to increase their share of the brain implant market.
Recent developments from key neural implant providers include:
- In April 2022, the FDA approved brain stimulation software for use in Parkinson’s disease. The Vercise Neural Navigator with Stimview XT enables clinicians to visualize lead placement and stimulation modeling, offering patient-specific 3D modeling for tailored therapy. This software is designed to aid in lead placement, reduce programming time, and enhance treatment decisions.
- In June 2021, Medtronic plc received FDA approval for its SenSight Directional Lead System, used in deep brain stimulation therapy.
Key Companies Profiled:
- Abbott Laboratories
- Medtronic PLC
- NeuroPace Incorporation
- Nevro Corporation
- Aleva Neurotherapeutics SA
- Synapse Biomedical Incorporation
- Boston Scientific Corporation
- Sapiens Neuro
- Edwards Lifesciences Corporation
Brain Implants Market Segmentation:
By Product Type:
- Deep Brain Stimulator
- Spinal Cord Stimulator
- Vagus Nerve Stimulator
By Application:
- Brain Implant for Chronic Pain
- Brain Implant for Epilepsy
- Deep Brain Simulation for Parkinson’s Disease
- Brain Implant for Depression
- Brain Implant for Essential tremor
- Brain Implant for Alzheimer’s Disease
By Region:
- North America
- Latin America
- Europe
- APAC
- MEA
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
